% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 39

Loading Chart...

8 inventors (with patents filed for the assignee):

Uri H Saragovi (5 out of 6 patents)

Phil Gold (5 out of 10 patents)

Claudio A Cuello (5 out of 6 patents)

4. Serge Moffett (4 out of 9 patents)

5. Pierre Du Ruisseau (4 out of 5 patents)

6. Nicole Bernard (3 out of 3 patents)

7. Dominic Melançon (1 out of 1 patent)

8. Serge Moffet (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 8629247 - Antibodies against prostate specific membrane antigen (2014-01-14),

2. 8512702 - Prostate cancer diagnosis and treatment (2013-08-20),

3. 8101713 - Prostate cancer diagnosis and treatment (2012-01-24),

4. 7910693 - Prostate cancer diagnosis and treatment (2011-03-22),

5. 7811564 - Prostate cancer diagnosis and treatment (2010-10-12),

Company Overview

Proscan Rx Pharma Inc. is a leading pharmaceutical company specializing in the development and distribution of innovative healthcare products. With a focus on research and development, we strive to provide high-quality medications to improve the health and well-being of patients worldwide. Our diverse product portfolio includes a range of prescription drugs, over-the-counter medications, and specialty pharmaceuticals. We are committed to excellence in every aspect of our business, from product development to customer service.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#200 in Montreal

#2,851 in Canada

Montreal, Canada

Proscan Rx Pharma Inc.

Forward Citations = 39

8 inventors:

Uri H Saragovi (5 out of 6 patents)

Phil Gold (5 out of 10 patents)

Claudio A Cuello (5 out of 6 patents)

4. Serge Moffett (4 out of 9 patents)

5. Pierre Du Ruisseau (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Proscan Rx Pharma Inc.. Retrieved from https://idiyas.com/company/proscan-rx-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]